CELU Covered Call Strategy
CELU (Celularity Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements.
CELU (Celularity Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $20.0M, a beta of 0.54 versus the broader market, a 52-week range of 0.56-4.31, average daily share volume of 119K, a public-listing history dating back to 2019, approximately 115 full-time employees. These structural characteristics shape how CELU stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.54 indicates CELU has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on CELU?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
CELU snapshot
As of August 14, 2026, spot at $0.73, ATM IV 20.70%, IV rank 0.67%, expected move 5.93%. The covered call on CELU below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on CELU specifically: CELU IV at 20.70% is on the cheap side of its 1-year range, which means a premium-selling CELU covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 5.93% (roughly $0.04 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CELU expiries trade a higher absolute premium for lower per-day decay. Position sizing on CELU should anchor to the underlying notional of $0.73 per share and to the trader's directional view on CELU stock.
CELU covered call setup
The CELU covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CELU at $0.73 on that close, the first option leg uses a $0.77 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CELU chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CELU shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $0.73 | long |
| Sell 1 | Call | $0.77 | N/A |
CELU covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
CELU covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on CELU. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on CELU
Covered calls on CELU are an income strategy run on existing CELU stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
CELU thesis for this covered call
The market-implied 1-standard-deviation range for CELU extends from approximately $0.69 on the downside to $0.77 on the upside. A CELU covered call collects premium on an existing long CELU position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether CELU will breach that level within the expiration window. Current CELU IV rank near 0.67% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CELU at 20.70%. As a Healthcare name, CELU options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CELU-specific events.
CELU covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CELU positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CELU alongside the broader basket even when CELU-specific fundamentals are unchanged. Short-premium structures like a covered call on CELU carry tail risk when realized volatility exceeds the implied move; review historical CELU earnings reactions and macro stress periods before sizing. Always rebuild the position from current CELU chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on CELU?
- A covered call on CELU is the covered call strategy applied to CELU (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With CELU stock at $0.73 on the most recent close, the strikes shown on this page are snapped to the nearest listed CELU chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CELU covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the CELU covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 20.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CELU covered call?
- The breakeven for the CELU covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CELU market-implied 1-standard-deviation expected move in the same options snapshot is approximately 5.93%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on CELU?
- Covered calls on CELU are an income strategy run on existing CELU stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current CELU implied volatility affect this covered call?
- CELU ATM IV is at 20.70% with IV rank near 0.67%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.